enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. M2-PK Test - Wikipedia

    en.wikipedia.org/wiki/M2-PK_Test

    The M2-PK Test is a non-invasive screening method for the early detection of colorectal cancers and polyps which are known to be the precursors of colorectal cancer. The M2-PK Test which is used for stool analysis is available either as fully quantitative ELISA Test or as a rapid test that can be performed by any general practitioner without the need of a laboratory or any additional equipment.

  3. A new way to screen for colon cancer may be on the horizon ...

    www.aol.com/news/way-screen-colon-cancer-may...

    Colon cancer screening is generally recommended starting at age 45, but less than 60% of people who are eligible are up to date. “In an ideal world, everyone goes to get a first colonoscopy at 45.

  4. Blood test for colon cancer screening is approved by US ...

    www.aol.com/lifestyle/blood-test-colon-cancer...

    U.S. health regulators on Monday approved a first-of-its-kind blood test for colon cancer, offering a new way of screening for a leading cause of cancer deaths. Test manufacturer Guardant said the ...

  5. Cancer screening - Wikipedia

    en.wikipedia.org/wiki/Cancer_screening

    While many screening tests (such as the fecal occult blood test or PSA test) are non-invasive, it is important to note that mammography (breast cancer screening) involves ionizing radiation exposure. [10] The breast is highly radiation sensitive, and it receives an approximate dose of 2.6 milligrays per mammography screening. [11]

  6. A blood test for colon cancer performed well in a study ...

    www.aol.com/news/blood-test-colon-cancer...

    In the U.S., screening is recommended for healthy adults ages 45 to 75 at average risk for colon cancer. Frequency depends on the test: a routine colonoscopy is every 10 years.

  7. Exact Sciences Corp. - Wikipedia

    en.wikipedia.org/wiki/Exact_Sciences_Corp.

    Exact Sciences Corp. is an American molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer; in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer.

  8. Tumor M2-PK - Wikipedia

    en.wikipedia.org/wiki/Tumor_M2-PK

    M2-PK, as measured in feces, is a potential tumor marker for colorectal cancer.When measured in feces with a cutoff value of 4 U/ml, its sensitivity has been estimated to be 85% (with a 95% confidence interval of 65 to 96%) for colon cancer and 56% (confidence interval 41–74%) for rectal cancer. [1]

  9. This blood test screens for 50 different types of cancer. Is ...

    www.aol.com/lifestyle/blood-test-screens-50...

    Currently, only five cancers have standard screening tests: breast, colorectal, cervical, lung and prostate. The majority of cancers don’t have one, which means MCED tests have the potential to ...